Nanohydroxyapatite vs Fluoride Varnish for MIH Front Teeth
Official title: Comparative Evaluation of Nanohydroxyapatite and Sodium Fluoride Varnishes in Remineralizing MIH-Affected Young Permanent Anterior Teeth
Run by Tanta University · NCT07894510 · Data updated 2026-11-12
This trial tests whether a nanohydroxyapatite varnish can remineralize MIH-affected front teeth in 8–11 year-olds as effectively as a standard 5% fluoride varnish.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 11 Years |
| Sex | All |
| Enrollment | 26 (estimated) |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Status | Recruiting |
| Started | January 3, 2026 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07894510 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 8–11 with MIH-affected permanent incisors and non-cavitated ICDAS 1–2 lesions.
✕Probably not a fit
Children with advanced decay, orthodontic appliances, or non-MIH enamel defects may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized trial, 26 children with MIH-affected permanent incisors and non-cavitated lesions are assigned to nanohydroxyapatite varnish or fluoride varnish. The study uses standardized home care with non-fluoridated toothpaste and follows participants for 6 months. Remineralization is measured by ICDAS scores and DIAGNOdent readings at 1, 3, and 6 months. Outcomes focus on lesion progression or reversal and overall remineralization efficacy. The study is conducted at Tanta University with no listed collaborators.
Why it matters
Potential benefit: If successful, the nanohydroxyapatite varnish could offer an alternative remineralization option for MIH-affected teeth.
How similar studies have gone: Previous work has shown remineralization potential with nano-HAp in similar contexts, but direct head-to-head comparisons with fluoride varnish are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Child had one or more MIH-affected permanent incisors exhibiting a non-cavitated initial carious lesion on the labial surface. * Lesions with a score of 1 or 2 according to the International Caries Detection and Assessment System (ICDAS). * Healthy children without any systemic disease. Exclusion Criteria: * Severely decayed, fractured, or restored MIH-affected teeth that can't be evaluated for varnish effects. * Presence of orthodontic appliances. * Developmental defects of enamel other than MIH (Amelogenesis imperfecta, dentinogenesis imperfecta, erosion, dental fluorosis). * Uncooperative patient and parent.
Where it's running
-
faculty of dentistry, Tanta university
Tanta, Egypt Recruiting
Study contacts
- Study coordinator: shaimaa eldesouky, assistant professor
- Email: shaimaaeldesouky@dent.tanta.edu.eg
- Phone: 01008994242
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Color of the defect and enamel breakdown in MIH-affected first molars
This study tests whether the color of the enamel defect in kids with MIH can predict enamel breakdown in their first permanent molars.
-
Colour and sensitivity in first permanent molars with MIH
This study tests whether the colour of enamel defects in first permanent molars with MIH correlates with hypersensitivity in affected children.
-
Comparing Clinpro Clear and Duraphat varnishes for dentin hypersensitivity in young adults
This test will see if a single application of Clinpro Clear or Duraphat reduces dentin hypersensitivity in adults aged 18–40.
-
Titania nanoparticle–infused fluoride varnish vs conventional fluoride varnish for plaque control in fixed braces
This will test whether a fluoride varnish that contains titania nanoparticles reduces dental plaque more than regular fluoride varnish in people aged 16–30 who are starting fixed orthodontic braces.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.